Price
No data yet.
Social Signal Score
Revenue
$68.8KCompany Profile
- CEO
- Jacob D. Cohen
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 3
- Beta
- 2.05
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -5.29
Financials
Revenue
$68.8K+669.2%Net Income
$-1.31MEBITDA
$-767.4KFree Cash Flow
$-260.5KEPS (diluted)
$-0.09Shares Outstanding (diluted)
17.12M+1616.0%Operating Expenses
$570.0KCash & Debt
$228.7KReturn of Capital
$588.0KQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $456.0K | $-20.64M | $-2.17 |
| 2024 | $615.9K | $-8.71M | $-4.40 |
| 2023 | $731.5K | $-9.21M | $-6.45 |
| 2022 | $8.9K | $-2.00M | $-1.73 |
| 2021 | $0.00 | $-17.7K | $-0.02 |
Valuation
MGRXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+0.00%Social Signal Score
Mentions (4)
- Newsbenzinga.com·4d ago·Neutral
Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Friday.
View source ↗ - Newsglobenewswire.com·4d ago·Neutral
Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche Subsidiary-Level Investment Provides Capital to Advance Commercialization of the Company's Antiviral Intellectual Property Portfolio with No Issuance of MGRX Common Stock
View source ↗ - Newsbusinesswire.com·50d ago·Neutral
MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Mangoceuticals, Inc. (NASDAQ: MGRX) and Nuclea Energy Inc. Halper Sadeh encourages Mangoceuticals shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.c…
View source ↗ - Newsnewsfilecorp.com·53d ago·Neutral
Nuclea Energy, Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96 million in private investment and public funding from Canada and the U.S. Department of Energy. Asset-led transaction to add intellectual property and development materials related principally to the SSR-W advanced reactor and WATSS spent nuclear fuel recycling technologies.
View source ↗
Insider trading
Open-market buys and sells by MGRX officers and directors.
- Bought
- $275k
- Sold
- $214k
1 trade
6 trades
- Johnston Eugene Msold
- Johnston Eugene Msold
- Johnston Eugene Msold
- Hamilton Alex P.sold
- Hamilton Alex P.sold
- Hamilton Alex P.sold
- Cohen Jacob D.boughtdirector, 10 percent owner, officer: Chief Executive Officer·275,000 @ $1.00·$275k·Apr 10, 2023·filing
41 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in MGRX.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.